Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin PK After IM Injection in Knee Osteoarthritis
NCT04427540Phase 2Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- Peptides
01
Overview
A Phase 2 trial of oxytocin in osteoarthritis (OA), sponsored by Wake Forest University Health Sciences. Planned start Dec 2021; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04427540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04427540.